Medical Devices industry M&A deals total $7.4bn in North America in April 2021

Total medical devices industry M&A deals worth $7.4bn were announced in North America in April 2021, led by $5bn merger of CA Healthcare Acquisition and LumiraDx, according to GlobalData’s deals database.

The value marked an increase of 207.5% over the previous month of $2.41bn and a rise of 1.5% when compared with the last 12-month average of $7.3bn.

North America held an 80.81% share of the global medical devices industry M&A deal value that totalled $9.17bn in April 2021. With an 80.81% share and deals worth $7.41bn, the US was the top country in North America’s M&A deal value across medical devices industry.

In terms of M&A deal activity, North America recorded 25 deals during April 2021, marking a decrease of 3.85% over the previous month and a flat growth over the 12-month average. The US recorded 23 deals during the month.

North America medical devices industry M&A deals in April 2021: Top deals

The top five medical devices industry M&A deals accounted for 98.4% of the overall value during April 2021.

The combined value of the top five medical devices deals stood at $7.29bn, against the overall value of $7.4bn recorded for the month.

The top five medical devices industry M&A deals of April 2021 tracked by GlobalData were:

1) The $5bn merger of CA Healthcare Acquisition and LumiraDx

2) The $1.8bn acquisition of Luminex by DiaSorin

3) InVitae’s $200m acquisition of Genosity

4) The $187m acquisition of Better Therapeutics by Mountain Crest AcquisitionII

5) The merger of D8 and Vicarious Surgical for $102.15m.